Trade Summary

1 week ago, Malcolm Jan, serving as Dir at United Therapeutics Corp (UTHR), sold 50 shares at $512.12 per share, for a total transaction value of $25,606.00. Following this transaction, Malcolm Jan now holds 420 shares of UTHR.

This sale represents a 11.00% decrease in Malcolm Jan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, December 23, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, meaning the disclosure happened on the same day as the trade.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.